Skip to main content
. Author manuscript; available in PMC: 2017 Sep 18.
Published in final edited form as: Dig Dis Sci. 2016 Jun 10;61(9):2732–2740. doi: 10.1007/s10620-016-4198-y

Table 1.

Characteristics of cirrhotic versus non-cirrhotic patients hospitalized for management of severe hematochezia

Clinical characteristics Cirrhotics
N = 160
Non-cirrhotics
N = 700
P value
Age (years) 57.9 ± 11.9 65.8 ± 16.1 <0.0001
Men 98 (61) 449 (64.1) 0.5065
In-hospital onset of bleeding 75 (47) 150 (21.4) <0.0001
Major concomitant chronic disorder 79 (49.7) 290 (41.4) 0.0558
Non-steroidal anti-inflammatories 10 (6.3) 91 (13) 0.0170
Aspirin 17 (10.6) 266 (38) <0.0001
Anticoagulation 13 (8.1) 113 (16.1) 0.0098
Antiplatelet agent 3 (1.9) 31 (4.4) 0.1355
Bleeding manifestations
  Hypotension 47 (29.4) 164 (23.4) 0.1126
  Shock 2 (1.3) 16 (2.3) 0.4101
  Syncope 8 (5) 48 (6.9) 0.3925
History of
  Melena 48 (30.2) 141 (20.1) 0.0064
  Hematemesis 21 (13.1) 26 (3.7) <0.0001
Positive nasogastric aspirate 14 (17.7) 12 (3.3) <0.0001
Laboratory measurements
  Hemoglobin (g/dl) 8.7 ± 1.7 8.9 ± 2.3 0.02
  Platelet count (cell/mm3) 105,563 ± 74,666 204,004 ± 104,081 <0.001
  Creatinine (mg/dl) 1.9 ± 3.4 1.6 ± 2.8 0.29
  Partial thromboplastin time (s) 35.7 11.4 28.7 ± 6.8 <0.0001
  Hematocrit (%) 26 ± 5 29 ± 6 <0.0001
  Blood urea nitrogen (mg/dl) 31.8 ± 23.6 27.3 ± 25.0 0.09
  International normalized ratio 1.6 ± 0.5 1.3 ± 0.76 0.01
Number of transfusions
  Packed red blood cell 4.3 ± 4.9 2.9 ± 3.6 <0.0001
  Fresh frozen plasma 2.2 ± 4.9 0.7 ± 2.3 <0.0001
  Platelets 1.2 ± 2.8 0.5 ± 3.0 <0.0001

Values are mean ± SD or numbers (%) of observations